Alcoholic liver disease: Treatment

被引:55
作者
Suk, Ki Tae [1 ]
Kim, Moon Young [2 ]
Baik, Soon Koo [2 ]
机构
[1] Hallym Univ, Coll Med, Dept Internal Med, Chunchon 200704, South Korea
[2] Yonsei Univ, Wonju Severance Christian Hosp, Wonju Coll Med, Dept Internal Med, Wonju 220701, South Korea
关键词
Liver disease; Alcoholic; Treatment; SHORT-TERM SURVIVAL; PROTEIN-CALORIE MALNUTRITION; RANDOMIZED CONTROLLED-TRIAL; DE-NOVO MALIGNANCIES; AND/OR HEPATITIS-B; DOUBLE-BLIND; FATTY LIVER; NUTRITIONAL SUPPORT; ENTERAL NUTRITION; RETROSPECTIVE ANALYSIS;
D O I
10.3748/wjg.v20.i36.12934
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The excess consumption of alcohol is associated with alcoholic liver diseases (ALD). ALD is a major healthcare problem, personal and social burden, and significant reason for economic loss worldwide. The ALD spectrum includes alcoholic fatty liver, alcoholic hepatitis, cirrhosis, and the development of hepatocellular carcinoma. The diagnosis of ALD is based on a combination of clinical features, including a history of significant alcohol intake, evidence of liver disease, and laboratory findings. Abstinence is the most important treatment for ALD and the treatment plan varies according to the stage of the disease. Various treatments including abstinence, nutritional therapy, pharmacological therapy, psychotherapy, and surgery are currently available. For severe alcoholic hepatitis, corticosteroid or pentoxifylline are recommended based on the guidelines. In addition, new therapeutic targets are being under investigation. (C) 2014 Baishideng Publishing Group Inc. All rights reserved.
引用
收藏
页码:12934 / 12944
页数:11
相关论文
共 129 条
  • [111] Nutrition in Alcoholic Liver Disease
    Singal, Ashwani K.
    Charlton, Michael R.
    [J]. CLINICS IN LIVER DISEASE, 2012, 16 (04) : 805 - +
  • [112] Soyka Michael, 2008, Curr Drug Abuse Rev, V1, P280
  • [113] Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study
    Spahr, L
    Rubbia-Brandt, L
    Frossard, JL
    Giostra, E
    Rougemont, AL
    Pugin, J
    Fischer, M
    Egger, H
    Hadengue, A
    [J]. JOURNAL OF HEPATOLOGY, 2002, 37 (04) : 448 - 455
  • [114] Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: A randomized trial
    Spahr, Laurent
    Lambert, Jean-Francois
    Rubbia-Brandt, Laura
    Chalandon, Yves
    Frossard, Jean-Louis
    Giostra, Emiliano
    Hadengue, Antoine
    [J]. HEPATOLOGY, 2008, 48 (01) : 221 - 229
  • [115] Stallings William, 2007, J Okla State Med Assoc, V100, P354
  • [116] Review article: nutritional therapy in alcoholic liver disease
    Stickel, F
    Hoehn, B
    Schuppan, D
    Seitz, HK
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (04) : 357 - 373
  • [117] Suk Ki Tae, 2012, Korean J Hepatol, V18, P1, DOI 10.3350/kjhep.2012.18.1.1
  • [118] Alcoholic liver disease and the gut-liver axis
    Szabo, Gyongyi
    Bala, Shashi
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (11) : 1321 - 1329
  • [119] Patterns of alcohol consumption after liver transplantation
    Tang, H
    Boulton, R
    Gunson, B
    Hubscher, S
    Neuberger, J
    [J]. GUT, 1998, 43 (01) : 140 - 145
  • [120] DETERMINANTS OF PROGRESSION TO CIRRHOSIS OR FIBROSIS IN PURE ALCOHOLIC FATTY LIVER
    TELI, MR
    DAY, CP
    BURT, AD
    BENNETT, MK
    JAMES, OFW
    [J]. LANCET, 1995, 346 (8981) : 987 - 990